Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.
To improve serodiagnostic methods for the diagnosis of acute toxoplasmosis during pregnancy, a new test system has been developed and evaluated based on the use of recombinant antigens. Five recombinant Toxoplasma gondii antigens (ROP1, MAG1, SAG1, GRA7, and GRA8) were cloned in Escherichia coli, purified, and applied directly onto nitrocellulose membranes in a line assay (recomLine Toxoplasma). A panel of 102 sera from 25 pregnant women with supposed recent toxoplasmosis and from two symptomatic children was compared to a panel of 71 sera from individuals with past infection. Both panels were analyzed using a recombinant line assay for immunoglobulin G (IgG), IgM, and IgA antibodies and a reference enzyme-linked immunosorbent assay. Within the IgM-positive samples, antibodies against ROP1 were predominant regardless of the infection state. In IgG analysis a characteristic antibody pattern was found for very recent infections. This pattern changed to a different one during the time course of infection: antibodies against GRA7 and GRA8 were characteristic for very early IgG, whereas antibodies against SAG1 and MAG1 appeared significantly later. These results were further confirmed by determination of the IgG antibody avidity for every single recombinant antigen. In the time course of infection, IgG antibodies against the early recognized antigens matured significantly earlier than those directed against the later antigens did. The IgA patterns did not give reliable information about the infection time points. The data revealed that the recombinant line assay provides valuable information on the actual state of infection, especially during the early infection time points.
Pfrepper
Klaus-Ingmar
KI
MIKROGEN molekularbiologische Entwicklungs GmbH, Neuried, Germany. pfrepper@mikrogen.de
Enders
Gisela
G
Gohl
Marion
M
Krczal
Doris
D
Hlobil
Harald
H
Wassenberg
Doris
D
Soutschek
Erwin
E
D000818:Animals; D000915:Antibody Affinity; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology*; D002648:Child; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000097:blood*; D010272:Parasitic Diseases / Q000276:immunology; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis / Q000276:immunology; D011994:Recombinant Proteins / Q000235:genetics*; D012698:Serologic Tests; D013997:Time Factors; D014122:Toxoplasma / Q000235:genetics / Q000276:immunology*; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000276:immunology*
D000953:Antigens, Protozoan; D007136:Immunoglobulins; D011994:Recombinant Proteins